Telomir announces in-vitro anti-cancer activity to advance osteosarcoma research
Telomir reported preclinical findings from The Ohio State University demonstrating Telomir-Zn inhibits cell growth in both human and canine osteosarcoma models, supporting parallel development pathways.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day